证券研究报告·公司点评报告·光伏设备 帝科股份（300842） 2025 一季报点评：N 型保持高占比，25H2 高 铜浆有望量产突破 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 9,603 | 15,351 | 16,878 | 18,753 | 20,822 | | 同比（%） | 154.94 | 59.85 | 9.95 | 11.11 | 11.03 | | 归母净利润（百万元） | 385.64 | 359.96 | 392.95 | 524.07 | 668.75 | | 同比（%） | 2,336.51 | (6.66) | 9.16 | 33.37 | 27.61 | | EPS-最新摊薄（元/股） | 2.74 | 2.56 | 2.79 | 3.72 | 4.75 | | P/E（现价&最新摊薄） | 13.83 | 14.82 | 13.57 | 10.18 | 7.98 | [Tab ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative increase in stock price of over 20% compared to the benchmark index within the next six months [10][16]. Core Insights - The company has demonstrated steady growth in revenue and profit, with 2024 revenue reaching 24.062 billion yuan, a 6.53% increase, and net profit attributable to shareholders at 1.529 billion yuan, up 8.26% [3][10]. - The gross profit margin for 2024 was 40.12%, reflecting a 1.91 percentage point increase, primarily due to improved margins in retail sales of traditional Chinese and Western medicines [4]. - The company has adopted a strategy of "regional focus and steady expansion," successfully increasing its store count to 14,684 by the end of 2024, with a net addition of 1,434 stores [6][9]. Financial Performance Summary - For 2024, the company reported a net operating cash flow of 4.221 billion yuan, a decrease of 8.70% year-on-year, while the investment cash flow was negative at -3.609 billion yuan, down 21% [5]. - The company expects revenue growth to continue, with projected revenues of 26.497 billion yuan, 29.168 billion yuan, and 32.131 billion yuan for 2025, 2026, and 2027 respectively, alongside net profits of 1.762 billion yuan, 2.028 billion yuan, and 2.336 billion yuan for the same years [10][12]. - The company’s financial ratios indicate a healthy growth trajectory, with a projected PE ratio decreasing from 21.82 in 2024 to 14.28 by 2027, suggesting increasing valuation attractiveness [12][15].

Investment Rating - The report maintains a "Recommended" investment rating for the company, indicating an expectation to outperform the benchmark index by 10%-20% over the next six months [22]. Core Insights - The company's Q1 2025 revenue reached 1.579 billion yuan, representing a year-over-year increase of 78.55% and a quarter-over-quarter increase of 4.79%. The net profit attributable to shareholders was 200 million yuan, showing a year-over-year increase of 656.87% and a quarter-over-quarter increase of 37.63% [1]. - The report highlights strong growth driven by AI server demand, with expectations for new capacity and customers to continue contributing to revenue growth in the second half of the year [1][7]. - The company is experiencing significant improvements in product structure and profitability, with a gross margin of 29.84% and a net margin of 12.67% in Q1 2025, reflecting a substantial increase from previous periods [7]. Financial Performance Summary - Total revenue projections for the company are as follows: 2024A at 4.687 billion yuan, 2025E at 7.549 billion yuan, 2026E at 10.024 billion yuan, and 2027E at 11.654 billion yuan, with respective year-over-year growth rates of 43.2%, 61.1%, 32.8%, and 16.3% [3]. - The net profit attributable to shareholders is projected to grow from 332 million yuan in 2024A to 1.988 billion yuan in 2027E, with year-over-year growth rates of 1,428.2%, 206.5%, 55.8%, and 25.4% [3]. - The report indicates a significant increase in R&D investment, reaching 91 million yuan in Q1 2025, up 87.08% year-over-year, aimed at supporting the development of next-generation AI servers and high-speed switches [7]. Market Position and Future Outlook - The company is positioned to benefit from the rapid growth of the AI industry, with expectations for continued demand for AI servers and high-speed switches, particularly as major clients like Amazon ramp up production of AI-related products [7]. - The report anticipates that the company's capacity expansion and successful project progress in high-speed switches will drive sustained revenue growth, with profit forecasts for 2025-2027 set at 1.017 billion yuan, 1.585 billion yuan, and 1.988 billion yuan respectively [7].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][6]. Core Insights - The company reported strong performance in Q1 2025, with revenue of 7.9 billion yuan (up 15.3% year-on-year) and net profit of 1.6 billion yuan (up 28.7% year-on-year). The overall revenue for 2024 was 29.5 billion yuan (up 19.9% year-on-year) and net profit was 5.1 billion yuan (up 18.6% year-on-year) [6]. - The company is expected to maintain its leading position in the industry due to its global capacity expansion, with projected net profits of 6.10 billion yuan, 6.94 billion yuan, and 7.75 billion yuan for 2025, 2026, and 2027 respectively [6]. Financial Performance - In 2024, the company achieved a gross margin of 30.0% (down 1.6 percentage points) and a net profit margin of 17.3% (down 0.2 percentage points). For Q1 2025, the gross margin improved to 32.5% (up 2.1 percentage points) and the net profit margin increased to 19.7% (up 2.1 percentage points) [7]. - The company sold 91.07 million square meters of artificial turf in 2024 (up 25.5%), with significant revenue contributions from leisure turf (20.5 billion yuan, up 22.4%) and sports turf (5.9 billion yuan, up 6.4%) [8]. Revenue Breakdown - The international market contributed 26.2 billion yuan in revenue in 2024 (up 20.9%), accounting for 88.9% of total revenue, while domestic revenue was 3.3 billion yuan (up 13.0%) [8]. - The company is focusing on refined operations in key regions and increasing new customer development to further enhance its global market share [8]. Financial Summary and Valuation Metrics - The company’s projected earnings per share (EPS) for 2025, 2026, and 2027 are 1.52 yuan, 1.73 yuan, and 1.93 yuan respectively, with corresponding price-to-earnings (P/E) ratios of 13.1, 11.5, and 10.3 [9]. - The financial metrics indicate a stable growth trajectory, with revenue expected to reach 33.83 billion yuan in 2025, reflecting a year-on-year growth of 14.6% [9].

证券研究报告 2025 年 04 月 29 日 湘财证券研究所 公司研究 康华生物（300841.SZ）业绩点评 狂苗销量阶段性下降，渠道拓展稳步推进 相关研究： 1. 《狂苗领域技术及临床先发 优势明显，诺如疫苗带来业绩新 增长极》 20241203 公司评级：买入（维持） 近十二个月公司表现 % 1 个月 3 个月 12 个月 相对收益 11 -7 -18 绝对收益 13 1 -29 核心要点： ❑ 公允价值变动影响 2024Q4 利润端，高基数及费用率上升影响 2025Q1 业绩 根据公司 2024 年年报及 2025 年一季报，2024Q4 公司实现营业收入 3.71 亿元，受参股公司确认公允价值变动损失影响（合计-5868.82 万元），归母 净利润为-725 万元，扣非归母净利润 4492.55 万元。2024Q1 公司营收 3.11 亿元，其中包括重组六价诺如病毒疫苗海外授权首付款 1.06 亿元，剔除上 年同期首付款后，2025Q1 营收同比下降 32.75%，扣非归母净利润同比下 降 65.5%。 2024 年受研发项目阶段性投入减少，研发费用率为 9.22%，同比下降 6.82pct；受市 ...

Investment Rating - The report maintains a "Recommendation" rating for Jiangsu Bank, indicating an expectation to outperform the benchmark index by 10%-20% over the next six months [2][21]. Core Views - Jiangsu Bank reported a strong Q1 2025 performance with operating income of CNY 22.3 billion, a year-on-year increase of 6.21%, and a net profit attributable to shareholders of CNY 9.78 billion, up 8.16% year-on-year. The non-performing loan (NPL) ratio improved to 0.86%, a decrease of 3 basis points from the beginning of the year, while the provision coverage ratio stood at 343.51%, down 6.59 percentage points from the start of the year [1][5]. Financial Performance Summary - **Operating Income and Profit**: - 2025 Q1 operating income reached CNY 22.3 billion, a 6.21% increase year-on-year - Net profit attributable to shareholders was CNY 9.78 billion, reflecting an 8.16% year-on-year growth [1][5]. - **Key Financial Metrics**: - Total revenue projections for 2024-2027 are CNY 80.82 billion, CNY 86.83 billion, CNY 95.22 billion, and CNY 102.60 billion respectively, with year-on-year growth rates of 8.80%, 7.44%, 9.67%, and 7.75% [1][6]. - Net profit attributable to shareholders is projected to grow from CNY 31.84 billion in 2024 to CNY 39.80 billion in 2027, with growth rates of 10.80%, 7.40%, 7.96%, and 7.80% [1][6]. - **Asset Quality**: - The NPL ratio is projected to remain stable at 0.89% from 2024 to 2027, while the provision coverage ratio is expected to decline from 351% in 2024 to 170% in 2027 [8][10]. - **Market Position**: - Jiangsu Bank's total assets reached CNY 4.46 trillion by the end of Q1 2025, a 12.84% increase from the beginning of the year, with total loans of CNY 2.26 trillion and deposits of CNY 2.42 trillion, reflecting growth rates of 7.96% and 14.18% respectively [5][6]. Investment Recommendation - The report suggests that Jiangsu Bank's governance is stable, with clear strategic planning and robust operational metrics. The bank's asset quality remains strong, and the current dividend yield is attractive. The target price for 2025 is set at CNY 11.66, based on a projected price-to-book (PB) ratio of 0.85x [2][5].

公司研究 证 券 研 究 报 告 瑞丰银行（601528）2025 年一季报点评 推荐（维持） 单季息差企稳回升，资产质量保持稳定 目标价：6.86 元 事项： 4 月 28 日晚，瑞丰银行披露 1Q25 季报，实现营业收入 11.09 亿元，同比增长 5.12%；营业利润 3.96 亿元，同比增长 4.04%；归属于上市公司股东的净利润 4.24 亿元，同比增长 6.69%。不良率环比持平于 0.97%，拨备覆盖率环比增加 5.2pct 至 326%。 评论： 农商行 2025 年 04 月 29 日 | | | 华创证券研究所 证券分析师：贾靖 邮箱：jiajing@hcyjs.com 执业编号：S0360523040004 证券分析师：徐康 电话：021-20572556 邮箱：xukang@hcyjs.com 执业编号：S0360518060005 证券分析师：林宛慧 邮箱：linwanhui@hcyjs.com 执业编号：S0360524110001 公司基本数据 | 总股本(万股) | 196,216.14 | | --- | --- | | 已上市流通股(万股) | 170,544.22 | | ...

Investment Rating - The investment rating for the company is "Buy-A" with a target price of 17.10 CNY for the next six months [4][6]. Core Views - The company has shown strong growth in overseas sales, with a year-on-year increase of 15.8% in Q1, driven by robust demand for small household appliances and increased inventory needs due to uncertainties in U.S. tariff policies [2]. - Domestic sales have shown marginal improvement, with a year-on-year decline of 4.9% in Q1, compared to a decline of 11.2% in Q4 2024, supported by government subsidies for replacing old appliances [2]. - The company's profitability has improved, with a net profit margin of 6.4% in Q1, up by 1.5 percentage points year-on-year, attributed to better investment returns and a favorable exchange rate [3]. Financial Performance Summary - In 2024, the company achieved a revenue of 16.82 billion CNY, a year-on-year increase of 14.8%, and a net profit of 1.05 billion CNY, up by 7.7% [1]. - For Q1 2025, the company reported a revenue of 3.83 billion CNY, a year-on-year increase of 10.4%, and a net profit of 0.25 billion CNY, up by 43.0% [1][3]. - The company's gross profit margin improved by 0.5 percentage points year-on-year, indicating better cost management and product mix [3]. Future Outlook - The company is expected to benefit from ongoing government subsidies for small household appliances, which will likely enhance domestic sales [4]. - The establishment of a manufacturing base in Indonesia is anticipated to mitigate trade policy risks and support stable growth in overseas sales [2]. - The projected earnings per share (EPS) for 2025 to 2027 are estimated to be 1.43 CNY, 1.62 CNY, and 1.88 CNY respectively, indicating a positive growth trajectory [7].

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The refrigerant industry is experiencing a high level of prosperity, with the company's performance expected to continue its strong growth [6] - The profitability of fluoropolymer materials is gradually recovering, driven by increased production and improved market conditions [6] Financial Performance Summary - In 2024, the company achieved operating revenue of 4.61 billion yuan, a year-on-year increase of 5.4%, and a net profit attributable to shareholders of 250 million yuan, up 36.8% year-on-year [4][7] - The company's Q4 2024 results showed operating revenue of 1.23 billion yuan, a year-on-year increase of 7.6%, and a net profit of 105 million yuan, up 385% year-on-year [5] - For Q1 2025, the company reported operating revenue of 1.14 billion yuan, a year-on-year increase of 12.4%, and a net profit of 97 million yuan, up 161.7% year-on-year [10] Product Segment Performance - In the fluorocarbon chemical segment, the company generated revenue of 2.447 billion yuan in 2024, with an average gross margin of 20.37%, up 12.62 percentage points year-on-year [7][9] - The fluoropolymer materials segment achieved revenue of 1.581 billion yuan in 2024, reflecting a year-on-year increase of 17.38% [7][9] - The chemical raw materials segment saw a revenue decline to 436 million yuan in 2024, with a significant drop in average selling price [9] Future Projections - The company is projected to achieve operating revenues of 5.012 billion yuan, 5.433 billion yuan, and 5.853 billion yuan for 2025, 2026, and 2027 respectively, with net profits of 491 million yuan, 589 million yuan, and 680 million yuan [11][13] - The expected price-to-earnings ratios for the next three years are 20, 17, and 15 times [11]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved a revenue of 1.723 billion yuan in 2024, representing a year-on-year growth of 14.45%, and a net profit attributable to shareholders of 192 million yuan, up 10.83% year-on-year [3] - In Q1 2025, the company reported a revenue of 317 million yuan, a year-on-year increase of 16.02%, and a net profit attributable to shareholders of 42 million yuan, growing 18.45% year-on-year [3] - The company is experiencing significant growth in overseas markets, with foreign revenue reaching 228 million yuan in 2024, up 33.38% year-on-year, accounting for 13.21% of total revenue [5][6] Summary by Sections Financial Performance - In 2024, the company's gross margin was 29.62%, an increase of 2.37 percentage points year-on-year, while the net margin was 11.16%, a slight decrease of 0.32 percentage points [6] - For Q1 2025, the gross margin was 29.86%, down 0.58 percentage points year-on-year, and the net margin was 13.84%, an increase of 0.89 percentage points [6] Product and Market Insights - The revenue from replacement consumables accounted for over 30% of total revenue, indicating a strong growth in the replacement market [5] - The company’s wind turbine filter unit generated revenue of 1.517 billion yuan in 2024, a year-on-year increase of 16.83%, while other products saw a slight decline in revenue [5] Inventory and Contract Liabilities - As of Q1 2025, the company's inventory was 834 million yuan, a year-on-year increase of 42.58%, and contract liabilities were 309 million yuan, up 101.32%, indicating a strong order backlog [6] Future Projections - The company is projected to achieve revenues of 2.695 billion yuan, 3.441 billion yuan, and 4.140 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 313 million yuan, 412 million yuan, and 515 million yuan [7][8]